Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIOAEROSOL SAMPLING DEVICE (BSD) CLINICAL STUDY: Performance of Respiratory Pathogen Bioaerosol Sampling Device Compared to Matched Swab Sample With Molecular and Antigen Assays That Can Detect SARS-CoV-2 Phase II Validation

NCT06047067 is registered in ClinicalTrials.gov with Cantor BioConnect, Inc. as lead sponsor.

NCT NCT06047067
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06047067 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIOAEROSOL SAMPLING DEVICE (BSD) CLINICAL STUDY: Performance of Respiratory Pathogen Bioaerosol Sampling Device Compared to Matched Swab Sample With Molecular and Antigen Assays That Can Detect SARS-CoV-2 Phase II Validation
Lead sponsor
Cantor BioConnect, Inc.
Phase
Observational
Overall status
Unknown status
Start date
July 10, 2023
Completion date
May 19, 2024
Enrollment
330 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19